Voluntis: AptarGroup : Voluntis and AliveCor Partner to Advance Management of Atrial Fibrillation for Patients with Cancer

(marketscreener.com) Voluntis, an Aptar Pharma company and leader in digital therapeutics, today announced that it has entered into a partnership agreement with AliveCor, Inc. , a leading innovator in FDA-cleared personal electrocardiogram technology. Under the collaboration, AliveCor's KardiaMobile device will be integrated with Theraxium, Voluntis'...https://www.marketscreener.com/quote/stock/APTARGROUP-INC-11708/news/AptarGroup-Voluntis-and-AliveCor-Partner-to-Advance-Management-of-Atrial-Fibrillation-for-Patients-37478555/?utm_medium=RSS&utm_content=20220106